AbbVie raised its full-year adjusted earnings guidance and reported higher first-quarter revenue, boosted by growth in its immunology and neuroscience portfolios.
Source link
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
Date:
More like thisRelated
Cecil Wilson competes at first NCFSR at 68 years old
Cecil Wilson is coming off the best season in...
Family speaks out, Santa Fe County plane crash, Warm weather, Gorge Bridge lawsuit, Rose concerns
Wednesday's Top Stories Wednesday's Five Facts Family says...